0001178913-23-003988.txt : 20231227
0001178913-23-003988.hdr.sgml : 20231227
20231227170037
ACCESSION NUMBER: 0001178913-23-003988
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231222
FILED AS OF DATE: 20231227
DATE AS OF CHANGE: 20231227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LIEBERMAN GERALD M
CENTRAL INDEX KEY: 0001234346
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38556
FILM NUMBER: 231518618
MAIL ADDRESS:
STREET 1: C/O ALLIANCE CAPITAL
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entera Bio Ltd.
CENTRAL INDEX KEY: 0001638097
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: KIRYAT HADASSAH, MINRAV BUILDING
STREET 2: FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
BUSINESS PHONE: 972-2-532-7151
MAIL ADDRESS:
STREET 1: KIRYAT HADASSAH, MINRAV BUILDING
STREET 2: FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
4
1
zk2330700.xml
X0508
4
2023-12-22
0
0001638097
Entera Bio Ltd.
ENTX
0001234346
LIEBERMAN GERALD M
KIRYAT HADASSAH,
MINRAV BUILDING, 5TH FLOOR
JERUSALEM
L3
9112002
ISRAEL
1
0
0
0
0
Ordinary Shares, par value NIS 0.0000769 per share
2023-12-22
4
P
0
23952
0.71
A
226961
D
Ordinary Shares, par value NIS 0.0000769 per share
6200
I
By Trust
Ordinary Shares, par value NIS 0.0000769 per share
6200
I
By Trust
Ordinary Shares, par value NIS 0.0000769 per share
6200
I
By Trust
Ordinary Shares, par value NIS 0.0000769 per share
6200
I
By Trust
Warrants (right to buy)
1.00
2023-12-22
4
P
0
23952
0.125
A
2023-12-22
2028-12-22
Ordinary Shares, par value NIS 0.0000769 per share
23952
23952
D
The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share ("Ordinary Shares"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules.
The Reporting Person's aggregate amount of Ordinary Shares in the Reporting Person's previous filings was inadvertently overstated by 11,200 shares. The aggregate amount has been properly adjusted in this Form 4.
These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
2023-12-27